Sanara MedTech Inc. (SMTI) Misses Q2 EPS by 2c

Sanara MedTech Inc. (NASDAQ: SMTI) reported Q2 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $28.14 million versus the consensus estimate of $28.95 million.

For earnings history and earnings-related data on Sanara MedTech Inc. (SMTI) click here.

You May Also Be Interested In

• Bessent on Iran: maximum economic pressure means likely not a kinetic restart
• Jefferies Downgrades Sunway Healthcare Holdings (SUNMED:MK) to Hold
• Twin Disc (TWIN) Tops Q4 EPS by 16c